TGFB1 and neoplasm: Particularly in metastatic urothelial immune-excluded tumors that show no response to atezolizumab, the authors found that there was an enrichment of a fibroblast TGF-β gene signature, and that the expression of this gene signature was directly linked to T cell trapping in the collagen-rich stroma surrounding the tumor (97).